Incorrect Statement in Text
JAMA · 2017
retinopathy or its progression to treatment.However, we disagree that our end point of "mild nonproliferative diabetic retinopathy or more severe stages" is not the relevant end point for epidemiologic studies of this type.First, we reported a more relevant end point than other similar studies have by excluding the "minimal" category, 3 thus increasing the likelihood that the findings were due to diabetes.Second, as this was the first thorough study of this end point in our cohort, it was not possible to examine progression of diabetic retinopathy or treatment.Only 1 participant with type 2 diabetes in this young cohort had proliferative diabetic retinopathy; all others had mild or moderate nonproliferative forms.